Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and Obesity
Clinical trial NCT07245771 · RECRUITING
Trial details
- NCT number
- NCT07245771
- Sponsor
- Ikaria Bioscience Pty Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-04
- Primary completion
- 2027-02-15
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.